Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Dividend declared
Quarterly results
Credit agrmnt [a]
Director departure
Appointed director
CC transcript
Asset disposition
Inv. presentation
|
|
ALLERGAN INC (AGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2015 |
SC 13D/A
| Pershing Square reports a 0% stake in ALLERGAN, INC. |
| 11/20/2014 |
SC 13D/A
| Pershing Square reports a 8.9% stake in ALLERGAN, INC. |
| 11/20/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a |
| 11/07/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
| 10/28/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a 9.7% stake in Allergan, Inc. |
| 09/23/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
| 09/16/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a 9.7% stake in Allergan, Inc. |
| 09/09/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
| 08/06/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
| 07/17/2014 |
SC 13D/A
| Valeant Pharmaceuticals International, Inc. reports a 9.7% stake in Allergan, Inc. |
| 07/17/2014 |
SC 13D/A
| Pershing Square reports a 9.7% stake in ALLERGAN, INC. |
|
|